It was recently announced at the 2013 International Congress on Neuropathic Pain that researchers have discovered inflammatory, neuropathic and immunologic roots to the diseased labeled CRPS. It had been previously established that CRPS was strictly a neurological ailment. This revelation means there is much work to do to discover a cure, but being on the right track is certainly a huge advancement.
Physicians are now likely to group CRPS patients into 3 groups according to their dysfunctions. According to anesthesiologynews.com, here are what the 3 groups would look like:
Group 1: Patients with deficits in temperature detection but no allodynia. They would have loss of nerve fiber, innervation and nerve degeneration.
Group 2: Normal temperature sensitivity but severe mechanical and thermal hyperalgesia.
Group 3: Inflammatory CRPS, with deep hyperalgesia and heat hyperalgesia but no hyperalgesia to prick testing.
Dr. Goebel of the University of Liverpool believes that some CRPS patients have an autoimmune, disorder related condition. He believes immunoglobulin could get to the root of the problem. A small sample size of patients felt between a 30% and 60% improvement of pain, during a controlled trial where patients were randomly given the drug.
Early diagnosis is very important when it comes to CRPS, because while the disease cannot be cured, it can be slowed considerably. The first move to be made is to contact the CRPS Institute in New York City. At The CRPS Institute, we know that the symptoms of CRPS are not just physical. Our goal is to help you recover all aspects of your life and return you to a healthy and active lifestyle. The CRPS Institute team includes the most renowned specialists in the fields of Interventional Pain Management, Anesthesiology, Physical and Occupational Therapy and Mental Health.